Medical Director
PhaseV
Medical Director
PhaseV
SaaS platform for adaptive clinical trials
PhaseV is redefining how clinical trials are designed and run. Using advanced causal machine learning and generative AI, we help biopharma and biotech companies make faster, more accurate, and more efficient development decisions — detecting hidden signals in clinical data and turning them into actionable insights across the trial lifecycle.
Headquartered in Cambridge, MA with our R&D and medical teams based in Tel Aviv, PhaseV is backed by leading investors including Insight Partners and Accel, and has raised $65M to date. We work with top pharmaceutical companies, biotechs, and CROs — and our platform has driven reported outcomes of up to 40% reductions in enrollment time, 50% lower trial costs, and 30%+ higher probability of trial success.
Our platform is built around four core modules:
We're looking for a Medical Director to join our Tel Aviv team and serve as a key clinical voice across all four PhaseV product modules — partnering with data scientists, engineers, and product teams internally, and engaging directly with pharma, biotech, and CRO clients externally. This is a hybrid role requiring a minimum of 4 days/week in our Tel Aviv office, reflecting how much we value in-person collaboration across our clinical, data science, and product teams.
Clinical & Scientific Leadership
Business Development Support
New Product Development
Required
Preferred
PhaseV is an equal opportunity employer.
PhaseVTrials provides a subscription-based software platform that helps pharmaceutical companies, biotech firms, and research teams design, manage, and run adaptive clinical trials. It combines reinforcement learning and causal machine learning to optimize decisions at any stage of a trial, with an intuitive user interface and flexible software architecture that adapts to different clinical needs. Users access the platform via SaaS and can also receive consulting help to fine-tune trial designs and execution strategies. Compared with others, PhaseVTrials offers a distinct mix of advanced data-driven algorithms and a user-friendly tool that delivers real-time insights, aiming to shorten trial timelines and reduce costs. The company’s goal is to accelerate drug development by enabling efficient, data-informed adaptive trials.
Explore more opportunities at PhaseV